Shopping Cart
Remove All
Your shopping cart is currently empty
Zilovertamab (UC-961) is a humanized anti-ROR1 monoclonal antibody that cuts off the WNT5A-induced ROR1 signaling pathway and shows anti-proliferative activity in ovarian and endometrial cancer cells. It can be used to study lymphatic cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | In Stock | In Stock | |
| 5 mg | $690 | In Stock | In Stock | |
| 10 mg | $1,120 | - | In Stock | |
| 25 mg | $1,660 | - | In Stock | |
| 50 mg | $2,230 | - | In Stock | |
| 100 mg | $2,950 | - | In Stock |
| Description | Zilovertamab (UC-961) is a humanized anti-ROR1 monoclonal antibody that cuts off the WNT5A-induced ROR1 signaling pathway and shows anti-proliferative activity in ovarian and endometrial cancer cells. It can be used to study lymphatic cancer. |
| In vitro | Zilovertamab (25 and 50 µg/mL; 72 h) inhibits the proliferation of high-grade serous ovarian cancer (HGSOC) cells[1]. Zilovertamab (50 µg/mL; 72 h) down-regulates the expression levels of ROR1 in CaOV3 at the transcriptional level[1]. |
| Synonyms | UC-961, Cirmtuzumab, 1643432-38-5 |
| Cas No. | 2485779-13-1 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.